LSTM 领衔最大规模 pooled 结核检测研究:Xpert MTB/RIF Ultra 试剂盒用量减半,单次成本降至不足 4 美元
Rapid low-cost diagnosis within reach for tuberculosis 'missed millions,' researchers find
LSTM 领衔的 Start4All 研究显示,将最多 4 份痰标本合并进一个 Xpert MTB/RIF Ultra 试剂盒检测,可使试剂盒用量减少 51%,单次成本从近 8 美元降至不足 4 美元。
These findings were generated by the largest-ever study of "pooled" tuberculosis (TB) testing, carried out by Start4All, a partnership led by LSTM with the Stop TB Partnership and research partners in seven countries with a high TB burden.
The study found that pooled sputum testing, which examines samples from several people in a single molecular test cartridge, halves the number of cartridges needed to make successful diagnoses.
The research team's paper on the performance and costs of pooled testing for molecular detection of TB has been published in The Lancet Global Health.
The study's first author, Dr. Tushar Garg, said the findings "demonstrate that the technique could increase access to accurate, rapid and low-cost TB testing, enabling thousands more people to be diagnosed around the globe."
Informing WHO guidelines
The findings directly informed World Health Organization guidelines on pooled testing issued earlier this year, which recommended the technique for adolescents and adults in resource-constrained settings.
Dr. Tom Wingfield, deputy director of LSTM's Centre for Tuberculosis Research and chief investigator on Start4All, said, "This is the evidence that took pooled testing from a promising idea to a WHO recommendation, and it comes from routine laboratories and clinics in the countries that need it most, not from a research setting.
"Pooling needs no new technology. It makes smarter use of the machines and cartridges laboratories already have, so that many more people can receive a rapid molecular test from the same budget.
"That is what reaching the missed millions looks like in practice."
Large-scale study
Between November 2023 and February 2025, more than 14,000 people with symptoms of TB in Bangladesh, Brazil, Cameroon, Kenya, Malawi, Nigeria and Vietnam took part in the study through screening in communities and at primary health centers and district hospitals.
Each person's sputum was tested on its own and again as part of a pool of up to four specimens on Xpert MTB/RIF Ultra, the most widely used rapid molecular TB test.
The study is the first to measure pooled testing against culture, the reference standard for TB diagnosis, rather than only against individual molecular testing.
Pooled testing used just over 7,000 cartridges instead of the roughly 14,000 that individual testing required, a 51% reduction, cutting the cost of each test from nearly $8 to less than $4.
There was a slight drop of 3.1% in the sensitivity (the number of people with TB correctly identified) of pooled testing compared with individual testing, mostly in specimens containing a very low TB bacterial load.
Cyrille Mbuli, a researcher from the Bamenda Center for Health Promotion and Research, the collaborating partner of Start4All in Cameroon, said, "The TB programs have been asking a simple question: What do we give up when we pool tests, and what do we gain?
"The Start4All results confirm what our laboratories have seen: pooling lets us test almost twice as many people for the same investment."
Deadliest single infection
Global efforts to tackle TB—the deadliest single infection, which kills around 1.3 million people a year—are hampered by the large number of people who remain undiagnosed and untreated and unknowingly spread TB in their homes and communities.
Chronic underinvestment has led to limited and inequitable access to WHO-recommended molecular rapid diagnostic tests, which only one in two people globally receive as their initial test.
This research is already having a real-world impact in communities around the world through the creation of a new toolkit for health care professionals and national TB programs, as well as a test cost calculator and decision tool developed by the Stop TB Partnership.
The paper is one of a series of Start4All outputs on pooled testing:
- An explanation of the role of pooled sputum testing in the global TB diagnostic landscape, published in The Lancet Respiratory Medicine;
- A multicountry qualitative study in BMJ Open, led by Dr. Vibol Iem at LSTM, found that laboratory staff, program managers and people with TB in the seven countries considered pooled sputum testing feasible and acceptable;
- A cross-sectional study in Clinical Microbiology and Infection reported the diagnostic accuracy and potential resource savings of pooled testing among adults in Vietnam.
In the next phase of Start4All, pooled testing will be combined with computer-aided chest X-ray triage and expanded to tongue swab specimens, supporting simpler and scalable approaches that can expand access to molecular TB testing.
Publication details
Tushar Garg et al, Diagnostic performance and testing costs of pooled testing for molecular detection of tuberculosis in seven countries: a prospective, observational, diagnostic accuracy study, The Lancet Global Health (2026). DOI: 10.1016/j.langlo.2026.104051
Journal information: Lancet Respiratory Medicine , BMJ Open , The Lancet Global Health
Key medical concepts
Who's behind this story?
Gaby Clark
MA in English, copy editor since 2021 with experience in higher education and health content. Dedicated to trustworthy science news. Full profile →
Andrew Zinin
Master's in physics with research experience. Long-time science news enthusiast. Plays key role in Science X's editorial success. Full profile →
Citation: Rapid low-cost diagnosis within reach for tuberculosis 'missed millions,' researchers find (2026, October 7) retrieved 7 October 2026 from https://medicalxpress.com/news/2026-10-rapid-diagnosis-tuberculosis-millions.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
来源:Medical Xpress · medicalxpress.com